- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03316846
Internet-delivered Cognitive Behavioral Therapy for Patients With Chronic Pain and Psychiatric Distress (TIPPS)
Tailored Internet-delivered Cognitive Behavioral Therapy for Patients With Chronic Pain and Comorbid Psychiatric Distress
This study is a randomized controlled trial studying the efficacy of an iCBT treatment for patients with chronic pain and comorbid psychiatric distress. Half the participants will receive treatment at first, while the other half serve as a control group. After the first group has received treatment, the same program will be offered to participants in the control group. Treatment will be tailored on the level of individual participants, enabling individuals suffering a wide range of problems to be recruited. The treatment will consist of a 10-week guided self-help program, followed by a booster program and follow-up one year later. During the curse of the treatment the participants will be guided via text communication by a licensed psychologist or a candidate psychologist on their last year of studies.
The primary hypothesis is that an individually tailored CBT-treatment administered through the internet can be beneficial for patients suffering from chronic pain and comorbid psychiatric distress. The investigators expect that patients in the treatment group will show reduced levels of disability, depression and anxiety, while improving on scales measuring coping and quality of life.
Study Overview
Status
Intervention / Treatment
Detailed Description
Patients suffering from chronic pain often experience comorbid psychiatric distress. Cognitive behavioral therapy (CBT) has been shown to be effective in treating both these problems. However delivering relevant treatment can be difficult due to logistics, cost and lack of personnel with required competence. Delivering CBT though the internet (iCBT) is a novel approach, sidestepping logistical issues while lowering costs. This however, is an area were research is lacking, and though there are several studies showing iCBT to be efficacious in treating both pain and psychiatric conditions, research on a combined approach is scarce.
This study will primarily investigate whether an individually tailored CBT-treatment administered through the internet can be beneficial for patients suffering from chronic pain and comorbid psychiatric conditions. The project will also clarify whether a following booster-program, also administered tough the internet, is helpful in maintaining and increasing effects of the initial treatment. Lastly, analysis of possible mediating variables will be able to give insight into the internal workings of the treatment itself, further elucidating efficacy of specific interventions, data which will be useful in future developments of treatment design.
The treatment will be based on a previously developed program, devised to target depression and anxiety in patients with chronic pain. The treatment will consist of a 10-week period where participants would get access to a series of treatment modules, each addressing a separate problem area using CBT techniques. The treatment includes modules addressing depression, anxiety, panic, worry, insomnia, stress, trauma, communication skills, and relaxation. The booster program will be based on the initial treatment, but will shorter, focusing on repetition, strategies for maintenance, and coping with setbacks. The platform used is an existing platform employed by Smärtcentrum at Uppsala university hospital for delivering internet based treatments.
The study will be conducted using a randomized controlled trial with a between-group design. Participants will be randomized to two groups, were one group will gain access to iCBT treatment while the second group will be a wait-list control, and will gain access to the program once treatment of the active group is finished. Participants will assessed by a licensed psychologist, and treatment modules assigned based on their individual needs. In addition to online CBT modules, consisting of information, exercises and homework assignments, all participants will have regular contact by secure email-channel with a licensed psychologist or last-year psychology student under supervision. This contact will guide treatment, providing support, feedback on homework, and if necessary clarify treatment content and help with IT-related problems interfering with treatment adherence. After a year, participants will be invited to take part in a follow-up module, consisting of limited treatment recapitulation and evaluation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Uppland
-
Uppsala, Uppland, Sweden, 75236
- Department of Psychology, Uppsala University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Experienced pain for at least the three previous months
- Medically evaluated regarding the pain condition
- Experiences at least one type of psychological distress such as: depression, anxiety, insomnia or stress
- Access to, and ability to use, a personal computer with internet access
- Mastery of the swedish language
Exclusion Criteria:
- Currently undergoing or planning to undergo CBT-treatment during the course of the study
- Currently undergoing or planning to undergo major changes in pharmacotherapy during the course of the study, or have made such changes in the last 2 months
- Have planned surgical intervention during the course of the study
- Currently experiencing symptoms of severe depression (scores >16 on suicidality on M.I.N.I.)
- Currently experiencing significant symptoms of psychosis (fulfills M.I.N.I criteria for psychotic syndrome, current)
- Currently experiencing significant symptoms of alcohol or substance abuse (fulfills M.I.N.I criteria for alcohol- or substance use disorder)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Internet-delivered therapy
10 week, guided and individually tailored internet-delivered cognitive behavioral therapy.
|
|
No Intervention: Wait list control group
Wait list control group, receives treatment at later point.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in depressive symptoms
Time Frame: at 10 weeks
|
Self reported change in depressive symptoms, Montgomery-Åsberg Depression Rating Scale (MADRS-S) Swedish version, 9 items
|
at 10 weeks
|
Change from baseline in depressive symptoms
Time Frame: at one-year
|
Self reported change in depressive symptoms, Montgomery-Åsberg Depression Rating Scale (MADRS-S) Swedish version, 9 items
|
at one-year
|
Change from baseline in psychosocial consequences of pain
Time Frame: at 10 weeks
|
Self reported psychosocial consequences of pain, West Haven-Yale Multidimensional Pain Inventory (WHY/MPI-S part 1), Swedish version, 22 items
|
at 10 weeks
|
Change from baseline in psychosocial consequences of pain
Time Frame: at one-year
|
Self reported psychosocial consequences of pain, West Haven-Yale Multidimensional Pain Inventory (WHY/MPI-S part 1), Swedish version, 22 items
|
at one-year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in anxiety sensitivity
Time Frame: at 10 weeks
|
Self reported anxiety sensitivity, Anxiety Sensitivity Index (ASI), Swedish version, 16 items
|
at 10 weeks
|
Change from baseline in anxiety sensitivity
Time Frame: at one-year
|
Self reported anxiety sensitivity, Anxiety Sensitivity Index (ASI), Swedish version, 16 items
|
at one-year
|
Change from baseline in symptoms of depression and anxiety
Time Frame: at 10 weeks
|
Self reported symptoms of depression and anxiety, Hospital Anxiety and Depression Scale (HADS), Swedish version, 14 items
|
at 10 weeks
|
Change from baseline in symptoms of depression and anxiety
Time Frame: at one-year
|
Self reported symptoms of depression and anxiety, Hospital Anxiety and Depression Scale (HADS), Swedish version, 14 items
|
at one-year
|
Change from baseline in pain disability
Time Frame: at 10 weeks
|
Self reported pain disability, Pain Disability Index (PDI), Swedish version, 7 items
|
at 10 weeks
|
Change from baseline in pain disability
Time Frame: at one-year
|
Self reported pain disability, Pain Disability Index (PDI), Swedish version, 7 items
|
at one-year
|
Change from baseline in quality of life
Time Frame: at 10 weeks
|
Self reported quality of life, Quality of Life Inventory (QOLI), Swedish version, 7 items
|
at 10 weeks
|
Change from baseline in quality of life
Time Frame: at one-year
|
Self reported quality of life, Quality of Life Inventory (QOLI), Swedish version, 7 items
|
at one-year
|
Fear of pain due to movement
Time Frame: Baseline only
|
Self reported fear of movement, Tampa Scale of Kinesiophobia (TSK), Swedish version, 17 items
|
Baseline only
|
Change from baseline in insomnia symptoms
Time Frame: at 10 weeks
|
Self reported insomnia symptoms, Insomnia Severity Index (ISI), Swedish version
|
at 10 weeks
|
Change from baseline in insomnia symptoms
Time Frame: at one-year
|
Self reported insomnia symptoms, Insomnia Severity Index (ISI), Swedish version
|
at one-year
|
Change from baseline in PTSD symptoms
Time Frame: at 10 weeks
|
Self reported PTSD symptoms, Post-Traumatic Stress Disorder checklist 5 (PCL-5), Swedish version
|
at 10 weeks
|
Change from baseline in PTSD symptoms
Time Frame: at one-year
|
Self reported PTSD symptoms, Post-Traumatic Stress Disorder checklist 5 (PCL-5), Swedish version
|
at one-year
|
Change from baseline in stress
Time Frame: at 10 weeks
|
Self reported stress, Shirom-Melomed Burnout Questionnaire (SMBQ), Swedish version
|
at 10 weeks
|
Change from baseline in stress
Time Frame: at one-year
|
Self reported stress, Shirom-Melomed Burnout Questionnaire (SMBQ), Swedish version
|
at one-year
|
Change from baseline in GAD-symptoms
Time Frame: at 10 weeks
|
Self reported GAD-symptoms , Generalized Anxiety Disorder 7 (GAD-7), Swedish version
|
at 10 weeks
|
Change from baseline in GAD-symptoms
Time Frame: at one-year
|
Self reported GAD-symptoms , Generalized Anxiety Disorder 7 (GAD-7), Swedish version
|
at one-year
|
Change from baseline in pain catastrophizing
Time Frame: at 5 weeks
|
Self reported pain catastrophizing, Pain Catastrophizing Scale (PCS), Swedish version
|
at 5 weeks
|
Change from baseline in pain catastrophizing
Time Frame: at 10 weeks
|
Self reported pain catastrophizing, Pain Catastrophizing Scale (PCS), Swedish version
|
at 10 weeks
|
Change from baseline in pain catastrophizing
Time Frame: at one-year
|
Self reported pain catastrophizing, Pain Catastrophizing Scale (PCS), Swedish version
|
at one-year
|
Change from baseline in coping strategies
Time Frame: at one-year
|
Self reported coping strategies , Coping Strategies Questionnaire - Revised (CSQ-R), Swedish version
|
at one-year
|
Change from baseline in coping strategies
Time Frame: at 5 weeks
|
Self reported coping strategies , Coping Strategies Questionnaire - Revised (CSQ-R), Swedish version
|
at 5 weeks
|
Change from baseline in coping strategies
Time Frame: at 10 weeks
|
Self reported coping strategies , Coping Strategies Questionnaire - Revised (CSQ-R), Swedish version
|
at 10 weeks
|
Change from baseline in pain acceptance
Time Frame: at 5 weeks
|
Self reported pain acceptance, Chronic Pain Acceptance Questionnaire (CPAQ), Swedish version
|
at 5 weeks
|
Change from baseline in pain acceptance
Time Frame: at 10 weeks
|
Self reported pain acceptance, Chronic Pain Acceptance Questionnaire (CPAQ), Swedish version
|
at 10 weeks
|
Change from baseline in pain acceptance
Time Frame: at one-year
|
Self reported pain acceptance, Chronic Pain Acceptance Questionnaire (CPAQ), Swedish version
|
at one-year
|
Change from baseline in self efficacy
Time Frame: at 5 weeks
|
Self reported pain related self efficacy, Pain Self Efficacy-2 (PSEQ-2), Swedish version
|
at 5 weeks
|
Change from baseline in self efficacy
Time Frame: at 10 weeks
|
Self reported pain related self efficacy, Pain Self Efficacy-2 (PSEQ-2), Swedish version
|
at 10 weeks
|
Change from baseline in self efficacy
Time Frame: at one-year
|
Self reported pain related self efficacy, Pain Self Efficacy-2 (PSEQ-2), Swedish version
|
at one-year
|
Treatment credibility rating
Time Frame: Baseline only
|
Self reported treatment credibility, Treatment Credibility Scale (TCS), Swedish version
|
Baseline only
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Gerhard Andersson, Professor, Linkoeping University
- Study Chair: Torsten Gordh, Professor, Uppsala University
- Study Director: Monica Buhrman, PhD, Uppsala University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 140371
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Assiut UniversityNot yet recruiting
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Istanbul UniversityCompletedLow Back Pain, Mechanical, Biofeedback, Pain, Chronic
-
Apurano Pharmaceuticals GmbHRecruitingPain | Lower Back Pain | Back Pain | Chronic Pain | Pain, Chronic | Chronic Pain Syndrome | Pain Syndrome | Lower Back Pain ChronicGermany
Clinical Trials on Internet-Delivered Cognitive Behavioral Therapy
-
Karolinska InstitutetRecruitingDepression | Anxiety Disorders | Insomnia | Psychiatric DisorderSweden
-
Karolinska InstitutetChild and Adolescent Psychiatry, StockholmRecruitingFunctional Abdominal Pain SyndromeSweden
-
Karolinska InstitutetCompletedObsessive-Compulsive DisorderSweden
-
Karolinska InstitutetVastra Gotaland Region; Region StockholmActive, not recruiting
-
Karolinska InstitutetRegion StockholmCompleted
-
Region SkaneLund UniversityRecruiting
-
University of AarhusUniversity of Southern DenmarkCompletedAnxiety DisordersDenmark
-
Megan PetrovTerminatedInsomnia Chronic | Subclinical Disease and/or SyndromeUnited States
-
University of PittsburghCompletedDepression | Anxiety | Sickle Cell DiseaseUnited States
-
Vilnius UniversityActive, not recruitingSleep | Tinnitus | Depression, Anxiety | Distress, EmotionalLithuania